Perianal Fistulizing Crohn’s Disease: Utilizing the TOpClass Classification in Clinical Practice to Provide Targeted Individualized Care
L Hanna(St. Mark's Hospital), Phil Tozer(St. Mark's Hospital), Marte Becker, Phillip Lung(St. Mark's Hospital), Séverine Vermeire(KU Leuven), Roel Hompes(Amsterdam University Medical Centers), Antonino Spinelli(Istituti di Ricovero e Cura a Carattere Scientifico), Lilli Lundby(Aarhus University), Corina Behrenbruch(The Royal Melbourne Hospital), Bram Verstockt(Universitair Ziekenhuis Leuven), Stefan D. Holubar(American Society of Colon and Rectal Surgeons), Shaji Sebastian(University of Hull), Silvio Danese(IRCCS Ospedale San Raffaele), Michele Carvello(Humanitas University), Jeroen Geldof(Ghent University Hospital), Ravi Misra(St. Mark's Hospital), Danny De Looze(Ghent University Hospital), K Gecse(Amsterdam University Medical Centers), Nik S. Ding(The University of Melbourne), Anders Dige(Aarhus University), Dirk Van de Putte(Ghent University Hospital), Benjamin L. Cohen(Cleveland Clinic), Sulak Anandabaskaran(St Vincent's Clinic), Jarmila van der Bilt, Kapil Sahnan(St. Mark's Hospital), Jean‐Frédéric LeBlanc(Hôpital du Sacré-Cœur de Montréal), Nusrat Iqbal(Worcestershire Acute Hospitals NHS Trust), Gordan Moran(Nottingham University Hospitals NHS Trust), Jean-Frédéric Colombel(Icahn School of Medicine at Mount Sinai), Amy L. Lightner(Scripps Clinic), André D’Hoore(KU Leuven), Ailsa Hart(Imperial College London), Gabriele Bislenghi(KU Leuven), Triana Lobatón, Christianne J. Buskens(Amsterdam Neuroscience), Serre-Yu Wong(Icahn School of Medicine at Mount Sinai)
Cited by 39
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k